"Discovery on Target" offers the opportunity to explore current "hot" targets, such as GPCRs, Kinases and Histone Deacetylases as well as to discover the "new kids on the block" which show a very promising future, such as Ubiquitin, Histone Methyl Transferases and PI3K. In addition, new developments and strategies to target some of the most prevalent diseases are being presented in focused meetings such as Cancer Cell Metabolism, Diabetes Drug Discovery, Allosteric Modulators and Functional Genomic Screening Strategies.
Celebrating 10 years, Cambridge Healthtech Institute's "Discovery on Target" is a leading event, recognized and well attended by the pharmaceutical and biotech industry and academic institutions alike.